AVEO Oncology to Present at the Deutsche Bank 2012 dbAccess BioFEST Conference
AVEO Oncology to Present at the Deutsche Bank 2012 dbAccess BioFEST Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- AVEO Oncology (NAS: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Deutsche Bank 2012 dbAccess BioFEST Conference on Monday, December 3, 2012 at 4:35 p.m. (ET) in Boston.
A live webcast of AVEO's presentation can be accessed by visiting the investors section of the company's website at investor.aveooncology.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation.
About AVEO
AVEO Oncology (NAS: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients' lives. AVEO's proprietary Human Response PlatformTM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company's website at www.aveooncology.com.
Investor:
AVEO Oncology
Monique Allaire, 617-299-5810
or
Media:
AVEO Oncology
Rob Kloppenburg, 617-930-5595
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS:
The article AVEO Oncology to Present at the Deutsche Bank 2012 dbAccess BioFEST Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
